Wall Street is positive on F-Star Therapeutics Inc (FSTX). On average, analysts give FSTX a Hold rating. The average price target is $7, which means analysts expect the stock to gain by 71.99% over the next twelve months. That average ranking earns FSTX an Analyst Rating of 6, which is better than 6% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating FSTX a Hold today. Find out what this means to you and get the rest of the rankings on FSTX!